-
341
-
342
-
343
-
344
-
345
-
346
-
347
-
348
-
349
Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
Published 2021Get full text
Article -
350
-
351
IX Forum on Translational Immunology and Cancer Immuno-therapy (FIT Cancer 9)
Published 2023-05-01“…FITCancer, which is the largest meeting uniquely focused on cancer immunotherapy, brings together clinicians and researchers, experts in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by GÉTICA’s members to the IX Forum on Translational Immunology and Cancer Immunotherapy.…”
Get full text
Article -
352
Advancing cancer immunotherapy: from innovative preclinical models to clinical insights
Published 2024-01-01“…Abstract The rapid expansion of cancer immunology and immunotherapy builds upon the success of early immune checkpoint inhibitors (ICI) and chimeric antigen receptor T cells for some cancer types. …”
Get full text
Article -
353
-
354
Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
Published 2023-01-01Get full text
Article -
355
Changes in the treatment landscape for metastatic urothelial cancer: current therapy and future directions
Published 2022-05-01“…A better understanding of molecular pathobiology of UC and advances in cancer immunology have led to a sharp increase in clinical trials for metastatic UC with the rapidly changing systemic treatment for this disease. …”
Get full text
Article -
356
-
357
-
358
-
359
-
360
Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
Published 2022Get full text
Article